Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066414
Filing Date
2025-05-08
Accepted
2025-05-08 08:00:20
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pepg-20250331.htm   iXBRL 10-Q 2174014
2 EX-31.1 pepg-ex31_1.htm EX-31.1 20498
3 EX-31.2 pepg-ex31_2.htm EX-31.2 19416
4 EX-32.1 pepg-ex32_1.htm EX-32.1 8741
5 EX-32.2 pepg-ex32_2.htm EX-32.2 8772
  Complete submission text file 0000950170-25-066414.txt   7090113

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20250331.xsd EX-101.SCH 923438
59 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20250331_htm.xml XML 972587
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 25923959
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)